J&L PHARMA
0849.895.390 · rovalta.com · 25/09/2026
J&L PHARMA
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOJ&L PHARMA is a Private limited company incorporated in 2012. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Antwerpen.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0849.895.390
- Incorporation
- 25/10/2012
- Legal form
- Private limited company
- Registered office
- Justitiestraat 81
2018 Antwerpen · FlandreSee on map - Contributed capital
- 12 500,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 13 filingsTrend over 13 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 54,5 k € | -21.7% | 69,6 k € | +64.9% | 42,2 k € | -21.3% | 53,7 k € | -13.5% | 62,1 k € |
| EBITDA | 54,2 k € | -22.0% | 69,5 k € | +66.0% | 41,9 k € | -21.9% | 53,6 k € | -13.1% | 61,6 k € |
| Operating result | 53,6 k € | -21.9% | 68,6 k € | +67.4% | 41 k € | -23.2% | 53,3 k € | -13.5% | 61,6 k € |
| Net result | 38,4 k € | -9.4% | 42,4 k € | +72.3% | 24,6 k € | -21.6% | 31,4 k € | -9.1% | 34,5 k € |
| Balance sheet | |||||||||
| Equity | 385,9 k € | +7.6% | 358,5 k € | +13.4% | 316,2 k € | +8.4% | 291,6 k € | +12.1% | 260,2 k € |
| Total assets | 664,5 k € | -2.2% | 679,7 k € | +1.8% | 667,5 k € | +0.2% | 666,4 k € | +0.6% | 662,4 k € |
| Cash | 3,7 k € | -2.8% | 3,8 k € | +4494% | 82,6 € | +115% | 38,4 € | -98.8% | 3,3 k € |
| Debts | 272,6 k € | -15.1% | 321,2 k € | -8.6% | 351,4 k € | -6.1% | 374,3 k € | -6.9% | 402,2 k € |
| Other | |||||||||
| Workforce | – | – | – | – | – | ||||
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active · 2 ended
Active mandates
Ended mandates
Other companies at this address
Justitiestraat 81 2018 Antwerpen| Company | CBE no. |
|---|---|
APOTHEEK JUSTITIA● Active | 0463.774.519 |
J & L DENTAL● Active | 0715.955.713 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 23/06/2026 | 24/07/2025 | 12/07/2024 | 02/08/2023 | 31/12/2022 | 31/08/2021 |
| General meeting | 22/06/2026 | 23/06/2025 | 24/06/2024 | 26/06/2023 | 27/06/2022 | 28/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 13 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 22/06/2026 | 23/06/2026 | Dutch | |
| Abridged model | 31/12/2024 | 23/06/2025 | 24/07/2025 | Dutch | |
| Micro model | 31/12/2023 | 24/06/2024 | 12/07/2024 | Dutch | |
| Micro model | 31/12/2022 | 26/06/2023 | 02/08/2023 | Dutch | |
| Micro model | 31/12/2021 | 27/06/2022 | 31/12/2022 | Dutch | |
| Micro model | 31/12/2020 | 28/06/2021 | 31/08/2021 | Dutch | |
| Micro model | 31/12/2019 | 22/06/2020 | 31/10/2020 | Dutch | |
| Micro model | 31/12/2018 | 24/06/2019 | 31/08/2019 | Dutch | |
| Micro model | 31/12/2017 | 25/06/2018 | 30/09/2018 | Dutch | |
| Abridged model | 31/12/2016 | 26/06/2017 | 11/01/2018 | Dutch | |
| Abridged model | 31/12/2015 | 27/06/2016 | 09/01/2017 | Dutch | |
| Abridged model | 31/12/2014 | 22/06/2015 | 30/12/2015 | Dutch | |
| Abridged model | 31/12/2013 | 23/06/2014 | 26/03/2015 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 100 k€ and 250 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 2 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202538,4 k €↓
- 2024Annual accounts 202442,4 k €↑
- 2023Annual accounts 202324,6 k €↓
- 2022Annual accounts 202231,4 k €↓
- 2021Annual accounts 202134,5 k €↑
- 2020Annual accounts 202028,8 k €↑
- 2019Annual accounts 201928,6 k €↓
- 2018Annual accounts 201832,3 k €↑
- 2017Annual accounts 201712,1 k €↓
- 2016Annual accounts 201616,8 k €↓
- 2015Annual accounts 201548,3 k €↓
- 2014Annual accounts 201454,4 k €↑
- 2013Annual accounts 201332 k €
- 25/10/2012IncorporationPrivate limited company